| Title : Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial - Guo_2024_Diabetes.Obes.Metab__ |
| Author(s) : Guo L , Tian F , Liu L , Chen M , Jiang C , Li S , Liu C , Zhang Y , Qin J , Yu D , Zong Y , Dai W |
| Ref : Diabetes Obes Metab , : , 2024 |
| Abstract : Guo_2024_Diabetes.Obes.Metab__ |
| ESTHER : Guo_2024_Diabetes.Obes.Metab__ |
| PubMedSearch : Guo_2024_Diabetes.Obes.Metab__ |
| PubMedID: 38602409 |
Guo L, Tian F, Liu L, Chen M, Jiang C, Li S, Liu C, Zhang Y, Qin J, Yu D, Zong Y, Dai W (2024)
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
Diabetes Obes Metab
:
Guo L, Tian F, Liu L, Chen M, Jiang C, Li S, Liu C, Zhang Y, Qin J, Yu D, Zong Y, Dai W (2024)
Diabetes Obes Metab
: